Targeting DDX3X suppresses progression of KRAS driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis Cell Death & Disease NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications Glutathione dependent degradation of SMARCA2 4 for targeted lung cancer therapy with improved selectivity ScienceDirect Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression: Cancer Cell